Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.01

€1.01

2.640%
0.0257
2.640%
€2.11
 
03.06.25 / Tradegate WKN: A1JUDY / Symbol: MVIS / Name: MicroVision / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:

MicroVision Inc Stock

There is an upward development for MicroVision Inc compared to yesterday, with an increase of €0.026 (2.640%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 2 € shows a very positive potential of 98.57% compared to the current price of 1.01 € for MicroVision Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for MicroVision Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of MicroVision Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of MicroVision Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
MicroVision Inc 2.640% -2.892% 3.038% -2.422% -34.427% -71.771% 14.066%
Fonar Corp. New - 4.167% 15.741% -12.587% -11.972% -14.384% -42.130%
Fluidigm Corp. -3.260% 0.565% -11.881% -60.268% -47.953% -50.307% -77.197%
Allscripts Healthcare -3.850% -3.846% 0.000% -64.286% -70.588% -84.177% -57.265%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-10

MicroVision, a company operating in the Healthcare Equipment & Supplies industry with the US symbol MVIS, presents an interesting financial picture. A cursory glance at the company's financial statements reveals some areas of concern, as well as certain promising aspects. The financials indicate potential challenges with liquidity, profitability, and operational efficiency. However, there are also signs of improvement in specific areas. In this detailed analysis, we will delve into the pros and cons of MicroVision's financials.

Reduced Net Loss: The year-over-year (YoY) net loss for MicroVision has been steadily decreasing. In 2020, it was -$13,634,000, improving to -$43,200,000 in 2021, and -$53,091,000 in 2022. This decrease in net losses can be considered a positive sign for the company, as it could indicate an improvement in financial performance.

Positive Cash Flow from Financing: The cash flow statements show positive cash flow from financing activities in recent years. For instance, it was $13,164,000 in the first quarter of 2023, which may suggest that the company is receiving adequate support from investors and lenders.

Comments

Prediction Buy
Perf. (%) 6.26%
Target price 2.213
Change
Ends at 21.05.26

MicroVision, Inc. (NASDAQ: MVIS) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $2.50 price target on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.76%
Target price 2.251
Change
Ends at 13.05.26

MicroVision, Inc. (NASDAQ: MVIS) had its price target lowered by analysts at D. Boral Capital from $3.00 to $2.50. They now have a "buy" rating on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -26.20%
Target price 1.851
Change
Ends at 25.03.26

MicroVision, Inc. (NASDAQ: MVIS) had its "buy" rating re-affirmed by analysts at Westpark Capital. They now have a $2.00 price target on the stock.
Ratings data for MVIS provided by MarketBeat
Show more

News

MicroVision Announces First Quarter 2025 Results: https://www.irw-press.at/prcom/images/messages/2025/79588/MicroVisionNR0512_PRcom.003.png
MicroVision Announces First Quarter 2025 Results

REDMOND, WA / ACCESS Newswire / May 12, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced its

MicroVision Attains TISAX Assessment, An Important Achievement in Global Auto Industry
MicroVision Attains TISAX Assessment, An Important Achievement in Global Auto Industry

REDMOND, WA / ACCESS Newswire / April 14, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that

MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025
MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025

REDMOND, WA / ACCESS Newswire / April 8, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, will host MicroVision